JCVI: Under-30s to be offered alternative to AZ vaccine
  • 3 years ago
The Joint Committee on Vaccination and Immunisation (JCVI) has issued new advice on the use of the Oxford-AstraZeneca vaccine, due to concerns over a very rare risk of blood clots. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Recommended